Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-005617

CVP, EMEACLA and JAPAC sold 6,640 shares at $88.68 ($588,835)

  • CVP, EMEACLA and JAPAC acquired 9,995 shares (option exercise)
  • CVP, EMEACLA and JAPAC gave up 328 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lemercier Jean-Luc M · CVP, EMEACLA and JAPAC

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-07 Exercise or conversion : show line 1 in the form 10b5-1 +3,355 172,417.78 D
2023-05-07 Shares withheld for taxes : show line 2 in the form 10b5-1 −224 $88.74 $19,878 172,193.78 D
2023-05-08 Shares withheld for taxes : show line 3 in the form 10b5-1 −104 $88.74 $9,229 172,089.78 D
2023-05-09 Exercise or conversion : show line 4 in the form 10b5-1 +6,640 $35.20 $233,706 178,729.78 D
2023-05-09 Sale : show line 5 in the form 10b5-1 −6,640 $88.68 $588,835 172,089.78 D
Open-market sales · 6,640 sh · avg $88.68 · $588,835

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-05-07 Exercise or conversion : show line 6 in the form 10b5-1 Performance Rights −3,355 2027-05-06 3,355 920 D
2023-05-09 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) −6,640 $35.20 2023-05-11 6,640 0 D
Loading xslF345X04/doc4.xml…